Bipolar disorder (BD) is a chronic mental illness characterized by alternations in mood, activity, sleep, and energy. Patients with BD suffer from marked functional impairments and a reduced quality of life[@b1]. As a result, BD is considered to be a major social burden[@b2]. In order to ameliorate this social burden, it is important to develop methods for the accurate diagnosis of BD, to prevent its onset, to provide more appropriate therapeutic strategies for its treatment, to increase the duration of inter-episode periods, and to improve its prognosis.

Research on the association between BD and circadian rhythms is an important key to understanding BD. Disturbances in circadian rhythms have been suggested to be core features of BD and are thought to play a fundamental role in BD pathophysiology[@b3]. A number of studies conclude that disruptions[@b4][@b5], phase shift[@b6][@b7], or instability[@b8] of circadian rhythms are related to BD. Moreover, genetic studies have suggested an association between circadian genes and BD[@b9][@b10][@b11][@b12]. The therapeutic effects of mood stabilizers such as lithium or valproate in treating BD are believed to be due to effects on the rhythmic properties of circadian genes and molecular clocks via the inhibition of glycogen synthase kinase-3β[@b13][@b14].

Light plays a primary role in the regulation of circadian rhythms, and light exposure is the main environmental cue for the synchronization of circadian rhythms in humans[@b15]. Excessive exposure to light at inappropriate times or a lack of light exposure at the required time may be involved in the pathophysiology of some mood disorders. Controlled therapeutic light exposure is usually used to treat certain mood disorders[@b15]. A previous study concluded that some subjects may be more sensitive to variations in natural bright light and that an increased sensitivity to light may be related to the development of affective disorders[@b16]. Seasonal variations in manic episodes have been reported to be related to the number of hours of daily sunshine[@b17]. Therefore, sensitivity to light exposure may be a characteristic feature of mood disorders.

A number of studies have investigated a broad range of variables, such as genetic factors, phenotypic manifestations, biomarkers, and neuroimaging patterns, in normal subjects at high risk for developing BD[@b18]. There are various methods used for the selection of subjects at risk of developing BD, including familial history of BD[@b19] or clinical features such as early onset and severity of depression, recurrent and atypical depression, subclinical mania, and psychosis[@b20]. Another method for selecting at-risk subjects is the use of clinical scales such as the childhood bipolar questionnaire[@b21], the bipolar-at-risk criteria[@b22], or the mood disorder questionnaire (MDQ)[@b23].

We hypothesized that normal subjects with high MDQ scores would be more sensitive to bright light exposure before bedtime and thus show more dramatic changes in molecular circadian rhythms, sleep parameters, and behavioral rhythms compared to subjects with low MDQ scores. We thus designed and performed a controlled experimental study to investigate this potential characteristic marker of subthreshold bipolarity in normal subjects.

Results
=======

Circadian rhythm of cortisol concentration in saliva
----------------------------------------------------

To investigate the impact of bright artificial light at night (ALAN) exposure before bedtime on circadian rhythm of cortisol concentration, we analyzed salivary cortisol concentrations of all 25 subjects using paired *t*-tests ([Table 1](#t1){ref-type="table"} and [Fig. 1](#f1){ref-type="fig"}). A significantly delayed acrophase in salivary cortisol concentration (t = −3.927, p = 0.001) was found in subjects after bright ALAN exposure. The mesor of cortisol concentration also significantly increased between nights (t = −2.494, p = 0.02). We found that bright ALAN exposure before bedtime in healthy adults significantly delayed the acrophase and increased the mesor of the circadian rhythm of cortisol concentration.

Next, we analyzed the changes in circadian rhythm of cortisol concentration over the course of the study between the two groups, namely the high MDQ score group and the low MDQ score group, after bright ALAN exposure using a repeated measures ANOVA ([Table 2](#t2){ref-type="table"} and [Fig. 2](#f2){ref-type="fig"}). Both groups showed a significantly delayed acrophase (F = 16.956, p \< 0.001) and a significant increase in mesor (F = 5.678, p = 0.026) of salivary cortisol concentration over the course of the study. The most noteworthy finding of the present study is the night---group interaction observed in the acrophase of the salivary cortisol concentration. We observed that the acrophase in the high MDQ score group was significantly delayed compared with that in the low MDQ score group (F = 8.528, p = 0.008). Altogether, bright ALAN exposure before bedtime caused a significantly delayed acrophase in cortisol concentrations in both groups. Moreover, the high MDQ score group was more sensitive to bright ALAN exposure, showing a significant increase in acrophase delay in cortisol concentration compared with the low MDQ score group.

Circadian rhythm of relative *PER1/ARNTL* gene expression levels in buccal epithelial cells
-------------------------------------------------------------------------------------------

To study the impact of bright ALAN exposure before bedtime on circadian rhythm of relative *PER1/ARNTL* gene expression, we used the same analysis as performed on cortisol concentration ([Table 1](#t1){ref-type="table"} and [Fig. 1](#f1){ref-type="fig"}). We found a significant delay in acrophase (t = −11.146, p \< 0.001) and a significant decrease in mesor of the relative *PER1/ARNTL* gene expression ratio (t = 2.638, p = 0.014) in subjects after bright ALAN exposure. The amplitude of relative *PER1/ARNTL* gene expression levels was significantly suppressed between nights after bright ALAN exposure (t = 6.555, p \< 0.001). We confirmed that bright ALAN exposure before bedtime in healthy adults significantly delayed the acrophase, decreased the mesor, and suppressed the amplitude of the circadian rhythm of the relative *PER1/ARNTL* gene expression ratio.

We investigated the changes in circadian rhythm of relative *PER1/ARNTL* gene expression ratio over the course of the study in the two groups after bright ALAN exposure using a repeated measures ANOVA ([Table 2](#t2){ref-type="table"} and [Fig. 2](#f2){ref-type="fig"}). Both groups exhibited a significantly delayed acrophase (F = 122.1, p \< 0.001), a reduced amplitude (F = 44.774, p \< 0.001), and a decrease in mesor (F = 7.338, p = 0.013) of relative *PER1/ARNTL* gene expression levels during the course of the study. However, there was no night---group interaction of the *PER1/ARNTL* gene expression ratio and no difference between groups.

Behavioral rhythm of actigraphy data
------------------------------------

There was no significant change between nights in the behavioral rhythm of actigraphy data after bright ALAN exposure before bedtime in subjects as a whole ([Table 3](#t3){ref-type="table"}). A repeated measures ANOVA on the behavioral rhythm showed no statistically significant differences between nights of the study in both groups. However, we found significant night---group interactions for the period of the behavioral rhythm (F = 7.844, p = 0.01), as shown in [Table 4](#t4){ref-type="table"}. The period of the behavioral rhythm in the high MDQ score group increased, whereas that in the low MDQ score group decreased between nights.

Sleep parameters of polysomnography
-----------------------------------

We analyzed sleep parameters of polysomnography in 21 subjects using the same method as above and found no significant differences between nights in subjects as a whole ([Table 3](#t3){ref-type="table"}). As shown in [Table 4](#t4){ref-type="table"}, a repeated measures ANOVA on sleep parameters showed no statistically significant differences between nights in both groups. However, there were significant night---group interactions for sleep parameters in stage N3 (F = 4.785, p = 0.041) and TA (F = 5.0, p = 0.038). Stage N3 showed a decreasing tendency in the high MDQ score group and an increasing tendency in the low MDQ score group. Stage TA showed an increasing tendency in the high MDQ score group and a decreasing tendency in the low MDQ score group.

Discussion
==========

We performed a controlled experimental study on young, healthy male adults divided into high and low MDQ score groups to investigate whether bright ALAN exposure affects molecular circadian rhythms, sleep parameters, and behavioral rhythms.

Both circadian gene rhythms and hormonal rhythms were shown to have a significant delay of acrophase after bright ALAN exposure when groups were considered separately and when all subjects were grouped together. Almost 99% of the populations of the U.S. and European countries experience significant ALAN. As a result, exposure to ALAN has become a part of modern everyday life[@b24][@b25][@b26]. Various studies have reported negative impacts of ALAN exposure on humans[@b15][@b25][@b27]. Bright light is a powerful factor in resetting the human circadian pacemaker independent of the timing of the sleep-wake cycle[@b28][@b29]. Therefore, bright light exposure may have broad effects on humans resulting from disturbance of the circadian system. Research on the effects of bright ALAN exposure on humans is limited[@b30][@b31]. Our study provides evidence that bright ALAN exposure just before bedtime significantly changes molecular circadian rhythms. Since circadian rhythms are closely related to a wide range of endocrine[@b32], immune[@b33], physical[@b34], and mental[@b35][@b36] states, it is very important to limit bright ALAN exposure before bedtime.

The most noteworthy finding of the present study is the observation of significant molecular circadian rhythm changes after bright ALAN exposure between the two different groups over the course of the study. Specifically, we observed a significantly delayed acrophase in the cortisol circadian rhythm after bright ALAN exposure in the high MDQ score group when compared to the low MDQ score group. This remarkable finding leads us to suggest that the hypersensitivity of the cortisol circadian rhythm to bright light exposure may be used as a possible biological marker for determining the risk of BD. Cortisol, an adrenal hormone essential for lipid and glucose metabolism, has been used as an important tool for studying circadian rhythms[@b37][@b38][@b39][@b40] as its circadian rhythm is synchronized with light exposure[@b41]. Because cortisol and its circadian rhythms are closely related to various mental states such as stress[@b42], major depression[@b43][@b44], post-traumatic stress disorder[@b45][@b46], and BD[@b47][@b48], it is important to study the relationship between the circadian rhythm of cortisol and the risk of BD. Interestingly, studies on plasma melatonin levels suggest that hypersensitivity to light may be a possible marker for manic-depressive illness[@b49][@b50]. Numberger *et al.* reported a hypersensitivity to melatonin suppression by light in young, healthy people at high risk for major affective disorders[@b51]. Karen *et al.* reported that melatonin secretion and sensitivity to bright nocturnal light are highly heritable[@b52]. The present study on multi-dimensional variables including cortisol levels is especially meaningful, as research on cortisol has been somewhat lacking in comparison to research focused on melatonin[@b48][@b53]. Several studies have examined cortisol in unaffected offspring of parents with BD, revealing a putative relationship to BD risk[@b54][@b55]. However, these studies provide limited information because cortisol levels were checked not by its circadian rhythm but by its simple level for measurement. To further investigate the link between cortisol levels and BD risk, the present study measured and analyzed the changes in the circadian rhythm of cortisol after bright ALAN exposure.

In addition to the circadian rhythms of cortisol concentration in saliva, this study also observed circadian rhythms of gene expression in buccal mucosa. The regulation of circadian gene expression may reflect the circadian systems of peripheral cells as well as the influence of cortisol rhythms and melatonin reflecting a central pacemaker localized in the suprachiasmatic nucleus (SCN)[@b56]. Several previous studies have shown that circadian rhythms of circadian gene expression occur not only in the SCN but also in peripheral organs[@b57][@b58][@b59][@b60][@b61]. In this study, to observe circadian rhythms of gene expression, we used mRNA extracted from buccal epithelial cells. In the preliminary research of this study, we tested five circadian genes (*ARNTL*, *PER1*, *PER2*, *PER3*, and *NR1D1*) extracted from buccal epithelial cells of five healthy people (independent from the present main study) who had been confirmed to show regular circadian rhythms by actigraphy and salivary cortisol concentration. However, the preliminary result did not show distinct circadian rhythms of gene expressions when each gene was observed alone ([Supplementary Figure S1A](#S1){ref-type="supplementary-material"}). It was because of several characteristics of buccal epithelial cells. First, buccal epithelial cells are necessarily collected together with saliva, which destroys RNA to protect the host from viral infection. Second, it is impossible to obtain the same number of buccal epithelial cells in each collection (performed by gently scraping the inner cheek using a cytological brush), leading to varying amounts of mRNA. Therefore, we decided to revise mRNA expression values by calculating their expression by ratio, as performed and validated in a previous study[@b62]. Among observed mRNA expression of five circadian genes, we observed more relevant circadian rhythms of *ARNTL* and *PER1* than in the others. The circadian rhythms of *ARNTL* and *PER1* were inverse in phase to each other ([Supplementary Figures S1A and S2](#S1){ref-type="supplementary-material"}), in agreement with previous studies[@b12][@b62][@b63][@b64][@b65]. Accordingly, to obtain the most distinguishable circadian rhythms, we investigated the relative gene expression of *ARNTL* and *PER1* and showed that the ratio of *PER1*/*ARNTL* in buccal epithelial cells is a reliable method for measuring circadian rhythms of peripheral circadian gene expression ([Supplementary Figures S1B and S2](#S1){ref-type="supplementary-material"}). Circadian gene expression patterns are known to directly reflect circadian rhythms in humans[@b66]. For this reason, the *PER1/ARNTL* gene expression ratio is thought to show the effects of bright ALAN exposure more directly and sensitively than other measures. However, we observed that the cortisol circadian rhythm was much more delayed than the *PER1*/*ARNTL* expression rhythm in the high MDQ score group compared to the low MDQ score group. We believe that this difference between the cortisol rhythm and the circadian gene rhythm suggests that BD risk is not related to circadian genes themselves but to the regulation of the circadian rhythm process after changes in the expression of core circadian genes.

Gaspar *et al.* reported that human genetic differences in major signaling pathways may be related to the light-dependent suppression of melatonin in BD[@b67]. Cortisol expression, which exhibits circadian rhythms reminiscent of those of melatonin, may be differentially affected by genetic differences in signaling pathways related to light-dependent changes based on the MDQ scores of subjects. On the other hand, expression levels of circadian genes are not considered suitable markers for predicting subthreshold bipolarity, as these genes are more directly affected by and more sensitive to bright ALAN exposure. The changes in these markers may thus predominantly reflect the effects of bright ALAN exposure.

We found significant night---group interactions for stage N3 and TA sleep parameters, as well as for the period of the behavioral rhythm. The night---group interactions for stage N3 and TA suggest that subjects with high MDQ scores may be more negatively affected by bright ALAN exposure before bedtime resulting in decreased deep sleep and increased arousal during sleep. However, interpretation of the results from this study is limited by the fact that parameters of stage N3 and TA and the period of the behavioral rhythm did not show significant differences between nights in either group.

We aimed to investigate the impact of bright ALAN exposure on a number of genetic, hormonal, and behavioral measures in normal subjects with high MDQ scores. The acrophase of the cortisol circadian rhythm was the only variable found to predict subthreshold bipolarity. This finding suggests that there may be a critical step related to BD along the pathway from gene expression to hormone production. This study was limited by a relatively small number of subjects and the fact that we were not able to specifically identify the pathway that determines BD risk. However, this study provides a significant advance in the field because it describes an experimental approach to examine our hypothesis, thereby introducing a meaningful way to elucidate causality of BD onset and recurrence in addition to identifying a putative method for predicting the risk of BD in normal subjects. In the future, we hope to verify the results of the present study and to advance our understanding further by using intensive molecular techniques on a larger number of subjects.

Methods
=======

Subjects
--------

From September 2013 to August 2014, a total of 29 healthy male adults ranging from 20 to 30 years of age (mean ± SD: 26.00 ± 2.89) were recruited for this study. For purposes of homogeneity, we decided to use only male subjects because data from female subjects may be more strongly influenced by hormonal changes such as the menstrual cycle. Advertisements for volunteers who "sleep like a baby" and "keep regular sleep-wake cycles" were posted on the internet bulletin boards of the Korea University to recruit these subjects. All volunteers were interviewed by psychiatrists specializing in sleep (authors HJL and CHC) in order to exclude volunteers who were overweight and suspected of snoring. Through in-depth interviews by psychiatrists with all volunteers, we confirmed that subjects had no personal or familial psychiatric history. All participants completed questionnaires regarding their sleep conditions and physical and psychiatric health. In particular, we gathered information about typical sleep patterns during weekdays and weekends as well as sleep environment and hygiene, including patterns of caffeine, alcohol, cigarette, and drug use. The MDQ, a subjective self-report screening tool, was used to assess subthreshold bipolarity. A high MDQ score (usually 7) is associated with an increased probability of BD[@b23]. The MDQ has been used as an assessment tool not only for the study of BD[@b23][@b68] but also for study of the risk of BD in the general population[@b69][@b70] or in subjects with major depressive disorder[@b71][@b72]. All participants provided informed written consent prior to enrollment after a full explanation and understanding of this study. The study protocol was approved by the Institutional Review Board of Korea University Anam Hospital (AN12261-010) and was conducted in accordance with the Declaration of Helsinki.

During the week prior to the main experiment, all participants were asked to wear a wrist actigraph (Actiwatch-L^®^, Mini Mitter) to verify that they were keeping a regular sleep-wake cycle. After reviewing the actigraphy data for each participant, we found one participant who showed a disturbed sleep-wake cycle characterized by excessive napping. Three participants dropped out of the study for personal reasons. The remaining 25 participants completed the entire experimental process. These participants were divided into two groups based on their MDQ mood scores: the high MDQ score group (MDQ score ≥ 7; mean ± SD: 9.571 ± 1.697; 14 subjects), and the low MDQ score group (MDQ score \< 7; mean ± SD: 2.091 ± 2.212; 11 subjects). Student's *t*-test or the Mann-Whitney test was performed to compare demographic characteristics between the high and low MDQ score groups according to a normality assumption. There were no differences in age (mean ± SD: 25.64 ± 2.53 vs. 24.91 ± 1.81, p = 0.43), weight (kg; 68.31 ± 10.43 vs. 70.10 ± 4.11, p = 0.60), or height (cm; 174.07 ± 5.55 vs. 176.45 ± 5.65, p = 0.30) as determined by Student's *t*-tests between high and low MDQ score groups, respectively. Similarly, there were no differences in education between the two groups (p = 0.168) as determined by a Mann-Whitney test.

Protocol
--------

[Figure 3](#f3){ref-type="fig"} shows an overview of the protocol used in this study. Beginning at one week prior to the main experiment, all participants were prohibited from napping during the daytime and permitted to sleep only at night in order to keep regular sleep-wake cycles. Sleep logs and wrist actigraph records were used to monitor adherence to these guidelines. All participants were prohibited from consuming medicine, coffee, or alcohol, because of potential effects on sleep-wake regularity. Moreover, they were instructed to limit light exposure to daily-living light after 20:00 h and were required to sleep at midnight and to wake up at 07:00 h. All participants maintained their normal daily living and slept in their own beds at home.

The main experimental study was carried out for 8 consecutive days and 7 nights. The study was divided into two phases based on differences in the intensity of ALAN: 2 nights at 150 lux and 5 nights at 1,000 lux. We designed and installed a controllable light box system in the experimental room to create the differences in light exposure. The system was installed by an illumination expert affiliated with the Korea Institute of Lighting Technology. The light box was installed in the ceiling of the experimental room so that the light illuminated the whole room. The experimental room was 30 m^2^ in size and had seven light-emitting diode (LED) lights, each with a size of 120 cm × 30 m, evenly distributed along the ceiling. The light illuminated the entire room and the light intensity was controlled using a dimmer. Only the staff were permitted to use the dimmer and control the intensity of lighting; all participants were prohibited from using the dimmer.

The subjects maintained their usual daily routine activities outside the unit during the daytime while wearing wrist actigraphs for monitoring their daily routine. Subjects were exposed to daily-living light (150 lux) for 4 hours (from 20:00 h to 24:00 h) before bedtime during the first 2 consecutive nights of the study. They were then exposed to bright light (1,000 lux) for 4 hours (from 20:00 h to 24:00 h) before bedtime during the next 5 consecutive nights of the study. The light intensity in the experimental room was checked on a nightly basis by an illuminometer (ANA-F11, Tokyo Photo, Japan) placed at horizontal eye level when sitting upright in a chair. Subjects read books or studied independently but were prohibited from watching television or using smartphones or tablets in the experimental room. All participants went to bed at the clinical trial center in the Korea University Anam Hospital every night of the study period, except during the nocturnal polysomnography (NPSG) session, which was performed in the sleep lab of the Sleep-Wake Disorders Center in the Korea University Anam Hospital. They were required to sleep at midnight and to wake up at 07:00 h during the study period in order to keep a consistent time-in-bed.

Saliva and buccal epithelial cells were collected from the subjects in order to analyze the circadian rhythms of cortisol and circadian gene expression. Sample collection was performed at 08:00 h, 12:00 h, 16:00 h, 20:00 h, and 24:00 h for the last 2 consecutive days of the experiment and was carried out by trained staff in the monitoring unit of the Sleep-Wake Disorders Center. The subjects were instructed to always be in the monitoring unit on time at every sampling point, so subjects maintained their daily routines during the 2 consecutive sampling days in the monitoring room. The subjects provided saliva samples directly into Salivettes (Sarstedt AG & Co., Nümbrecht, Germany) at each of the specified time points. The Salivette device was used according to the manufacturer's instructions and stored at −20 °C until the time of the assay. Immediately after saliva sample collection, buccal epithelial cell samples were collected by gently scraping both inner cheeks using a cytological brush. The buccal epithelial cell samples were immediately placed into RNAlater reagent (Sigma-Aldrich, St. Louis, MO, USA) and were then maintained at −20 °C until the time of analysis. The saliva samples were used to for the cortisol assay, and each participant's cortisol circadian rhythm was determined. cDNA was synthesized from total RNA of collected buccal epithelial cells, and circadian gene expression rhythms were determined using the *PER1/ARNTL* expression ratio.

NPSG was conducted on 3 different nights during the study period. Three nights before the main experiment, each participant underwent an initial NPSG session (Night 0) while maintaining a regular sleep-wake cycle and normal ALAN exposure before bedtime to reduce interference from the first-night effect. The second and third NPSG sessions (Nights 1 and 2) were conducted on the last night of each ALAN schedule.

Measurements
------------

### Measurement of cortisol concentration in saliva

The Coat-A-Count Cortisol assay (Siemens Healthcare Diagnostics, Inc., Los Angeles, USA), a direct double-antibody radioimmunoassay, was used for the determination of salivary cortisol levels. The kit was used according to the manufacturer's instructions. The analytical sensitivity of the assay was 0.01 μg/dL and the intra-assay coefficient of variation was 3% for samples with a mean concentration of 0.19 ± 0.10 μg/dL and 4% for samples with a mean concentration of 0.24 ± 0.02 μg/dL. The inter-assay coefficient of variation was 12% for samples with a mean concentration of 1.85 ± 0.10 μg/dL and 14% for samples with a mean concentration of 0.24 ± 0.02 μg/dL.

### Measurement of circadian gene expression level in buccal epithelial cells

The expression levels of circadian rhythm-related genes *PER1* and *ARNTL* were determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and the *PER1/ARNTL* ratio at each sampling time point was used to measure circadian rhythm. Total RNA was isolated from buccal epithelial cells using the RNeasy Micro Kit (Qiagen Inc., Valencia, CA, USA). The final elution of RNA was performed using 20 μL of RNase-free water. To synthesize cDNA, the whole RNA sample was reverse-transcribed in 40 μL reactions using the Sensiscript Reverse Transcription Kit (Qiagen Inc., Valencia, CA, USA) according to the manufacturer's protocol. Two-microliter aliquots of cDNA were amplified using Taqman PCR reactions in an Applied Biosystems StepOnePlus Real-Time PCR System (ThermoFisher Scientific, Foster City, CA, USA). The primers and Taqman probes used in this experiment are as follows; *PER1* (NM_002616): forward 5′-CTCACACAGCTCCTCCTCAG-3′, reverse 5′-TTTGTGCTCTTGCTGCTCTC-3′, probe 5′FAM-CGGCAAGGACTCAGCCCTGC-3′BHQ1; *ARNTL* (NM_001030272): forward 5′-TGCCTCGTCGCAATTGG-3′, reverse 5′-ACCCTGATTTCCCCGTTCA-3′, probe 5′FAM-CGACTGCATTCTCATGTAGTTCCACAACCA-3′BHQ1.

### Measurement of actigraphy data

We measured activity, sleep, and light exposure for each participant using the wrist actigraph and the Philips Respironics Actiware software Version 6.0.4 (Philips Respironics, Bend, OR, USA). Participants continuously wore the wrist actigraph on the non-dominant hand and only removed it during times when it might have got wet or damaged. All participants also completed a standardized diary to provide daily records of bedtime, wake-up time, naps, daytime activities, and any periods during which the wrist actigraph was removed. Actigraphy data collected from the wrist actigraph were compared with the self-reported standardized diaries to verify their accuracy.

### Measurement of sleep parameters

Sleep parameters from NPSG were scored manually according to the standard criteria of the American Academy of Sleep Medicine manual for the scoring of sleep and associated events[@b73]. Sleep parameters such as total sleep time (TST); sleep efficiency (SE); wake after sleep onset (WASO); sleep latency (SL); stages N1, N2, N3, and R, stage R latency; REM density; apnea hypopnea index (AHI); respiratory effort-related arousal index (RERA index); respiratory disturbance index (RDI; AHI + RERA index); percentage of supine position (Supine); periodic limb movement during sleep index (PLMS index); limb movement index (LM index); total arousal time (TA); and spontaneous arousal time (SA) were extracted from the scored results of each NPSG session. All sleep stages (N1, N2, N3, and R) were converted to percentages before analysis to adjust for the difference in TST of each subject on each night. We encountered technical problems, which led to incomplete data collection during the NPSG session for one case in the high MDQ score group and for three cases in the low MDQ score group. In total, NPSG data from 21 subjects (13 subjects in the high MDQ score group and 8 subjects in the low MDQ score group) were analyzed.

Data Analysis
-------------

Salivary cortisol concentrations and relative *PER1/ARNTL* gene expression levels at 8:00 h, 12:00 h, 16:00 h, 20:00 h, and 24:00 h from the last two consecutive days of each of the two different ALAN schedules were fitted with sine curves for sine regression analysis. Variables such as period, amplitude, acrophase, and mesor for each of the molecular circadian rhythms were then extracted for analysis. Sine regression analysis was performed using SigmaPlot software Version 10.0 (Systat Software, Inc., San Jose, CA, USA). The period, robustness, mesor, amplitude, and acrophase variables for behavioral rhythm were calculated from the physical activity data and analyzed using Cosinor software (Circadian Rhythm Laboratory of Boise State University, Boise, ID, USA).

In order to determine the impact of bright ALAN exposure before bedtime on all of the subjects, the circadian rhythm variables of salivary cortisol concentration, relative *PER1/ARNTL* gene expression levels, and behavioral rhythm and sleep parameters for each night were analyzed using paired *t*-tests or Wilcoxon signed-rank tests. The appropriate statistical test was chosen based on the results of normality tests performed for each of the variables using both the Kolmogorov-Smirnov and the Shapiro-Wilk methods.

To find differential effects of bright ALAN exposure before bedtime on the different groups on different nights, a repeated measures analysis of variance (ANOVA) was performed for each variable.
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![Altered molecular circadian rhythms of salivary cortisol and relative *PER1/ARNTL* expression levels following bright light exposure before bedtime.\
Twenty-five young, healthy male subjects were exposed to 150 lux artificial light at night (ALAN) before bedtime for 2 consecutive days. The circadian rhythms of salivary cortisol concentration (**A**) and relative *PER1/ARNTL* expression levels (**B**) are indicated as black circles connected with a continuous black line. After the 150 lux ALAN exposure, the same 25 subjects were exposed to 1,000 lux ALAN for 5 consecutive nights. The circadian rhythms of salivary cortisol concentration (**A**) and relative *PER1/ARNTL* expression levels (**B**) are indicated by white closed circles connected with a dashed black line. Data are expressed as mean ± standard error of the mean (SEM).](srep31846-f1){#f1}

![Altered molecular circadian rhythms of salivary cortisol concentration and relative *PER1/ARNTL* expression levels following bright light exposure before bedtime in high and low mood disorder questionnaire (MDQ) score groups.\
Fourteen young, healthy male subjects with subthreshold bipolarity (high MDQ score group) were exposed to 150 lux artificial light at night (ALAN) for 2 consecutive days. The circadian rhythms of salivary cortisol concentration (**A**) and relative *PER1/ARNTL* expression levels (**C**) are indicated by black circles connected with a continuous black line. After exposure to 150 lux ALAN, the same 14 subjects in the high MDQ score group were exposed to 1,000 lux ALAN for 5 consecutive days. The circadian rhythms of salivary cortisol concentration (**A**) and relative *PER1/ARNTL* expression levels (**C**) are indicated by white closed circles connected with a dashed black line. Eleven young, healthy male subjects with low risk of bipolar disorder (low MDQ score group) were exposed to 150 lux ALAN for 2 consecutive days. The circadian rhythms of salivary cortisol concentration (**B**) and relative *PER1/ARNTL* expression levels (**D**) are indicated by black circles connected with a continuous black line. After exposure to 150 lux ALAN, the same 11 subjects in the low MDQ score group were exposed to 1,000 lux ALAN for 5 consecutive days. The circadian rhythms of salivary cortisol concentration (**B**) and relative *PER1/ARNTL* expression levels (**D**) are indicated by white closed circles connected with a dashed black line. Data are expressed as mean ± standard error of the mean (SEM).](srep31846-f2){#f2}

![Protocol design.\
Sleep was scheduled from 00:00 to 07:00 during the 8 days of the experiment. On study days 1 and 2, the participants were exposed to 150 lux daily-living artificial light at night (ALAN) before bedtime. On study days 3, 4, 5, 6, and 7, the participants were exposed to 1,000 lux bright ALAN before bedtime. All daily-living and bright ALAN exposures were scheduled from 20:00 to 24:00. Samplings of salivary and buccal epithelial cells were scheduled with 4-hour intervals starting at 20:00 on study day 1 to 16:00 on study day 3 and from 20:00 on study day 6 to 16:00 on study day 8. No samples were collected during sleep times. Nocturnal polysomnography (NPSG) was conducted at three time points (Night 0, Night 1, and Night 2). Night 0 was in fact 3 nights before the main experimental study, during the regular sleep-wake cycle and daily-living ALAN exposure before sleep in order to reduce interference from the first-night effect. Nights 1 and 2 were the last nights of the 150 lux and the 1,000 lux ALAN exposure, respectively.](srep31846-f3){#f3}

###### Results of paired *t*-tests or Wilcoxon signed-rank tests on the circadian rhythm variables of salivary cortisol concentration and relative *PER1/ARNTL* gene expression levels between Night 1 and Night 2.

  Type of sample                                       Variables         Night 1          Night 2       t or Z           df           p-value(two tailed)
  ------------------------------------------------ ----------------- ---------------- ---------------- -------- -------------------- ---------------------
  Cortisol concentration (n = 25)                     Period (hr)     24.813 ± 0.777   25.175 ± 0.985   −1.523           24                  0.141
  Amplitude (μg/dL)                                  0.217 ± 0.033    0.205 ± 0.064        0.807          24           0.428         
  Acrophase (time)                                   9.935 ± 0.964    11.646 ± 1.936       −3.927         24      **0.001**^**†**^   
  Mesor (μg/dL)                                      0.272 ± 0.036    0.307 ± 0.048        −2.494         24      **0.020**^**†**^   
  Relative *PER1/ARNTL* gene expression (n = 25)    Period (hr)^\*^   24.237 ± 0.747   24.215 ± 0.880   0.040           ---                  0.968
  Amplitude                                         28.186 ± 3.487    22.103 ± 4.993       6.555          24     **\<0.001**^**‡**^  
  Acrophase (time)                                  15.886 ± 0.592    18.504 ± 0.965      −11.146         24     **\<0.001**^**‡**^  
  Mesor                                             25.919 ± 3.197    22.983 ± 4.698       2.638          24      **0.014**^**†**^   

^†^*p*-value \< 0.05.

^‡^*p*-value \< 0.001.

^\*^Wilcoxon signed-rank test.

Night 1, exposure to artificial light of 150-lux intensity at night.

Night 2, exposure to artificial light of 1,000-lux intensity at night.

Amplitude and Mesor of Relative *PER1/ARNTL* gene expression indicate the relative *PER1/ARNTL* gene expression ratio.

All variables except those tested using the Wilcoxon signed-rank test were analyzed by a paired *t*-test.

hr, hour; time, time of the day; TST, total sleep time; min, minutes; n, number of subjects; SD, standard deviation; and df, degrees of freedom.

###### Results of a repeated measures ANOVA of the circadian rhythm variables of salivary cortisol concentration and relative *PER1/ARNTL* gene expression levels between Nights 1 and 2 and high and low mood disorder questionnaire (MDQ) score groups.

  Type of sample                                      Variables          Nights       High MDQ score group (n = 14 or 13)   Low MDQ score group (n = 11 or 8)        Source                F             *p*
  ------------------------------------------------ ---------------- ---------------- ------------------------------------- ----------------------------------- ------------------ -------------------- -------
  Cortisol concentration (n = 25)                    Period (hr)        Night 1                 24.847 ± 0.838                       24.769 ± 0.729                  Nights              2.518          0.126
  Night 2                                           25.051 ± 0.913   25.333 ± 1.093                  Group                                0.142                      0.710                             
                                                                                                                                      Night\*Group                   0.554               0.464         
  Amplitude (μg/dL)                                    Night 1       0.223 ± 0.031               0.209 ± 0.036                           Nights                      0.809               0.378         
  Night 2                                           0.222 ± 0.064     0.182 ± 0.06                   Group                                4.248                      0.051                             
                                                                                                                                      Night\*Group                   0.033               0.400         
  Acrophase (time)                                     Night 1       9.866 ± 1.114              10.021 ± 0.775                           Nights                      16.956        **\<0.001**^**‡**^  
  Night 2                                           12.562 ± 1.668   10.481 ± 1.647                  Group                                5.995                 **0.022**^**†**^                       
                                                                                                                                      Night\*Group                   8.528          **0.008**^**†**^   
  Mesor (μg/dL)                                        Night 1       0.265 ± 0.035               0.283 ± 0.036                           Nights                      5.678          **0.026**^**†**^   
  Night 2                                           0.321 ± 0.039    0.288 ± 0.054                   Group                                0.531                      0.473                             
                                                                                                                                      Night\*Group                   3.792               0.064         
  Relative *PER1/ARNTL* gene expression (n = 25)     Period (hr)        Night 1                 24.225 ± 0.724                        24.252 ± 0.81                  Nights               0.01          0.920
  Night 2                                           24.226 ± 0.917    24.2 ± 0.875                   Group                               \<0.001                     0.999                             
                                                                                                                                      Night\*Group                   0.011               0.918         
  Amplitude                                            Night 1       27.383 ± 3.182             29.209 ± 3.737                           Nights                      44.774        **\<0.001**^**‡**^  
  Night 2                                           22.243 ± 5.848   21.925 ± 3.913                  Group                                0.258                      0.617                             
                                                                                                                                      Night\*Group                   1.335               0.260         
  Acrophase (time)                                     Night 1       16.118 ± 0.549             15.591 ± 0.529                           Nights                      122.1         **\<0.001**^**‡**^  
  Night 2                                           18.58 ± 0.906    18.408 ± 1.072                  Group                                2.728                      0.112                             
                                                                                                                                      Night\*Group                   0.549               0.466         
  Mesor                                                Night 1       25.799 ± 3.38              26.072 ± 3.105                           Nights                      7.338          **0.013**^**†**^   
  Night 2                                           23.722 ± 5.321   22.044 ± 3.798                  Group                                0.352                      0.559                             
                                                                                                                                      Night\*Group                   0.750               0.396         

^†^*p*-value \< 0.05.

^‡^*p*-value \< 0.001.

Night 1, exposure to artificial light of 150-lux intensity at night.

Night 2, exposure to artificial light of 1000-lux intensity at night.

Amplitude and Mesor of Relative *PER1/ARNTL* gene expression indicate the relative ratio of *PER1/ARNTL* gene expression.

hr, hour; time, time of the day; min, minutes; n, number of subjects; and SD, standard deviation.

###### Results of paired *t*-tests or Wilcoxon signed-rank tests of the behavioral rhythm and sleep parameters between Night 1 and Night 2.

  Type of sample                        Variables               Night 1            Night 2        t or Z    df     p-value (two tailed)
  ---------------------------- --------------------------- ------------------ ------------------ -------- ------- ----------------------
  Behavioral rhythm (n = 25)           Period (hr)           24.064 ± 0.617     23.900 ± 0.585    1.071     24            0.295
  Amplitude                         168.331 ± 53.029        184.816 ± 53.643        −1.085          24     0.289  
  Acrophase (time)                   15.649 ± 1.714          15.332 ± 1.436         0.662           24     0.515  
  Mesor                             243.126 ± 71.803        244.961 ± 59.853        −0.098          24     0.923  
  Robustness (%)                     24.008 ± 7.854          23.476 ± 5.277         0.301           24     0.766  
  Sleep parameters (n = 21)           TST (min)^\*^         384.380 ± 18.202   385.548 ± 16.381   −0.818    ---           0.413
  SE (%)                             97.433 ± 1.580          97.405 ± 1.775         0.099           20     0.922  
  WASO (min)^\*^                      6.024 ± 5.278           5.74 ± 5.449          −1.252         ---     0.211  
  SL (min)                            4.000 ± 2.617          4.520 ± 3.120          −0.732          20     0.473  
                                      Stage N1 (%)           12.262 ± 4.923     13.395 ± 6.688    −1.213    20            0.239
                                      Stage N2 (%)           45.267 ± 5.791     44.467 ± 5.865    0.535     20            0.598
                                      Stage N3 (%)           18.638 ± 7.386     17.557 ± 8.642    0.994     20            0.332
                                       Stage R (%)           23.848 ± 4.777     24.571 ± 3.761    −0.818    20            0.423
                                Stage R latency (min)^\*^   71.430 ± 42.432    71.762 ± 40.937    −0.709    ---           0.478
                                         RDI^\*^             4.067 ± 2.923      4.090 ± 3.470     −0.348    ---           0.728
                                           AHI               2.433 ± 0.382      2.400 ± 2.399     0.117     20            0.908
                                          RERAI              1.633 ± 1.451      1.720 ± 1.591     −0.633    20            0.534
                                        PLMI^\*^             2.150 ± 5.899      2.929 ± 8.166     −0.691    ---           0.490
                                         LMI^\*^             5.676 ± 6.419      6.933 ± 9,168     −0.869    ---           0.385
                                        TA (min)             12.952 ± 4.249     13.410 ± 5.311    −0.718    20            0.481
                                        SA (min)             8.052 ± 3.800      8.424 ± 4.537     −0.688    20            0.499
                                 Supine position (%)^\*^    77.790 ± 18.453    80.252 ± 20.704    −0.262    ---           0.793

^†^*p*-value \< 0.05.

^\*^Wilcoxon signed-rank test.

Night 1, exposure to artificial light of 150-lux intensity at night.

Night 2, exposure to artificial light of 1,000-lux intensity at night.

All variables except those tested using the Wilcoxon signed-rank test were analyzed by a paired *t*-test.

hr, hour; time, time of the day; TST, total sleep time; SE, sleep efficiency; WASO, wake time after sleep onset; SL, sleep latency; AHI, apnea + hypopnea index; RDI, respiratory disturbance index; RERAI, respiratory effort-related arousal index; PLMI, periodic limb movement during sleep index; LMI, limb movement index; TA, total arousal; SA, spontaneous arousal; min, minutes; n, number of subjects; SD, standard deviation; and df, degrees of freedom.

###### Results of a repeated measures ANOVA of the behavioral rhythm and sleep parameters between Nights 1 and 2 and high and low mood disorder questionnaire (MDQ) score groups.

  Type of sample                      Variables              Nights        High MDQ score group (n = 14 or 13)   Low MDQ score group (n = 11 or 8)      Source        F           *p*
  ---------------------------- ----------------------- ------------------ ------------------------------------- ----------------------------------- -------------- ------- ------------------
  Behavioral rhythm (n = 25)         Period (hr)            Night 1                  23.914 ± 0.728                       24.255 ± 0.391                Nights      2.375        0.137
  (n = 25)                             Night 2           24.086 ± 0.429              23.664 ± 0.687                            Group                    0.046       0.832  
                                                                                                                                                     Night\*Group   7.844   **0.010**^**†**^
                                      Amplitude             Night 1                 157.870 ± 37.402                     181.644 ± 67.692               Nights      0.839        0.369
                                       Night 2          196.098 ± 47.618            170.456 ± 59.610                           Group                    0.004       0.952  
                                                                                                                                                     Night\*Group   2.804        0.108
                                  Acrophase (time)          Night 1                  15.339 ± 1.695                       16.045 ± 1.736                Nights      0.518        0.479
                                       Night 2           15.279 ± 1.359              15.399 ± 1.593                            Group                    0.987       0.331  
                                                                                                                                                     Night\*Group   0.358        0.555
                                        Mesor               Night 1                 218.217 ± 74.838                     274.828 ± 55.845               Nights      0.013        0.911
                                       Night 2          248.568 ± 66.164            240.369 ± 53.528                           Group                    1.713       0.204  
                                                                                                                                                     Night\*Group   3.212        0.086
                                   Robustness (%)           Night 1                  24.921 ± 9.231                       22.845 ± 5.884                Nights      0.047        0.830
                                       Night 2           23.364 ± 4.939              23.618 ± 5.922                            Group                    0.196       0.662  
                                                                                                                                                     Night\*Group   0.417        0.525
  Sleep parameters                    TST (min)             Night 1                  387.12 ± 19.777                      379.94 ± 15.481               Nights      0.658        0.427
  (n = 21)                             Night 2          387.038 ± 17.578            383.125 ± 15.038                           Group                    0.528       0.476  
                                                                                                                                                     Night\*Group   0.725        0.405
                                       SE (%)               Night 1                  97.246 ± 1.624                       97.738 ± 1.561                Nights      0.006        0.940
                                       Night 2           97.200 ± 2.010              97.738 ± 1.369                            Group                    0.536       0.473  
                                                                                                                                                     Night\*Group   0.006        0.940
                                     WASO (min)             Night 1                   6.462 ± 4.850                        5.313 ± 6.193                Nights      0.255        0.619
                                       Night 2           6.500 ± 5.583                4.500 ± 5.345                            Group                    0.460       0.506  
                                                                                                                                                     Night\*Group   0.309        0.585
                                      SL (min)              Night 1                   4.308 ± 2.905                        3.500 ± 2.155                Nights      0.643        0.432
                                       Night 2            4.58 ± 2.907                4.44 ± 3.649                             Group                    0.190       0.668  
                                                                                                                                                     Night\*Group   0.197        0.662
                                    Stage N1 (%)            Night 1                  13.046 ± 5.067                       10.988 ± 4.716                Nights      0.729        0.404
                                       Night 2           15.262 ± 7.280              10.363 ± 4.469                            Group                    2.116       0.162  
                                                                                                                                                     Night\*Group   2.325        0.144
                                    Stage N2 (%)            Night 1                  45.708 ± 6.552                       44.550 ± 4.612                Nights      0.579        0.456
                                       Night 2           46.092 ± 6.024              41.825 ± 4.815                            Group                    1.696       0.208  
                                                                                                                                                     Night\*Group   1.022        0.325
                                    Stage N3 (%)            Night 1                  17.738 ± 8.495                       20.100 ± 5.310                Nights      0.283        0.601
                                       Night 2           14.946 ± 9.784              21.800 ± 4.009                            Group                    1.879       0.186  
                                                                                                                                                     Night\*Group   4.785   **0.041**^**†**^
                                     Stage R (%)            Night 1                  23.508 ± 5.740                       24.400 ± 2.852                Nights      0.946        0.343
                                       Night 2           23.685 ± 3.926              26.013 ± 3.186                            Group                    0.888       0.358  
                                                                                                                                                     Night\*Group   0.609        0.445
                                Stage R latency (min)       Night 1                  77.88 ± 45.513                       60.94 ± 37.282                Nights      0.017        0.897
                                       Night 2          76.346 ± 46.806              64.313 ± 30.495                           Group                    0.679       0.420  
                                                                                                                                                     Night\*Group   0.124        0.729
                                         RDI                Night 1                   4.646 ± 3.096                        3.125 ± 2.518                Nights      0.011        0.918
                                       Night 2            4.62 ± 3.655                3.23 ± 3.179                             Group                    1.099       0.308  
                                                                                                                                                     Night\*Group   0.028        0.869
                                         AHI                Night 1                   2.823 ± 1.836                        1.800 ± 1.489                Nights      0.001        0.971
                                       Night 2            2.62 ± 2.690                2.03 ± 1.946                             Group                    0.838       0.371  
                                                                                                                                                     Night\*Group   0.391        0.539
                                        RERAI               Night 1                    2.07 ± 2.53                          1.51 ± 1.34                 Nights      2.246        0.149
                                       Night 2            1.63 ± 1.96                  1.28 ± 1.17                             Group                    1.027       0.324  
                                                                                                                                                     Night\*Group   0.198        0.661
                                        PLMI                Night 1                   3.28 ± 7.356                         0.33 ± 0.709                 Nights      0.662        0.426
                                       Night 2          4.223 ± 10.2807               0.825 ± 1.086                            Group                    1.065       0.315  
                                                                                                                                                     Night\*Group   0.063        0.805
                                         LMI                Night 1                   6.892 ± 7.894                        3.700 ± 1.922                Nights      1.505        0.235
                                       Night 2           8.169 ± 11.440               4.925 ± 2.895                            Group                    0.883       0.359  
                                                                                                                                                     Night\*Group   0.001        0.980
                                      TA (min)              Night 1                  13.638 ± 4.409                       11.838 ± 3.996                Nights      0.054        0.820
                                       Night 2           15.115 ± 5.842              10.638 ± 2.811                            Group                    2.498       0.130  
                                                                                                                                                     Night\*Group   5.000   **0.038**^**†**^
                                      SA (min)              Night 1                   8.046 ± 3.649                        8.063 ± 4.294                Nights      0.036        0.852
                                       Night 2           9.300 ± 5.302                7.000 ± 2.622                            Group                    0.392       0.539  
                                                                                                                                                     Night\*Group   5.266        0.033
                                 Supine position (%)        Night 1                  76.823 ± 21.330                      79.363 ± 13.726               Nights      0.882        0.359
                                       Night 2          78.177 ± 21.308              83.625 ± 20.624                           Group                    0.222       0.643  
                                                                                                                                                     Night\*Group   0.237        0.632

^†^*p*-value \< 0.05.

Night 1, exposure to artificial light of 150-lux intensity at night.

Night 2, exposure to artificial light of 1000-lux intensity at night.

The numbers of subjects in the high MDQ score group (n = 14) and the low MDQ score group (n = 11) are for the variables of behavioral rhythm. However, sleep parameters have different numbers of subjects in each group: high MDQ score group (n = 13) and low MDQ score group (n = 8).

hr, hour; time, time of the day; TST, total sleep time; SE, sleep efficiency; WASO, wake time after sleep onset; SL, sleep latency; AHI, apnea + hypopnea index; RDI, respiratory disturbance index; RERAI, respiratory effort-related arousal index; PLMI, periodic limb movement during sleep index; LMI, limb movement index; TA, total arousal; SA, spontaneous arousal; min, minutes; n, number of subjects; and SD, standard deviation.

[^1]: These authors contributed equally to this work.
